The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Thesis: "SGRY offers a strong organic and inorganic growth profile and is well-positioned to benefit from ongoing secular tailwinds as more procedures transition from inpatient hospitals into the ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

RBC Capital analyst Frank Morgan maintained a Buy rating on Surgery Partners (NASDAQ:SGRY) Inc on Thursday, setting a price target of $70, which is approximately 39.08% above the... RBC Capital ...

Buy SGRY near 20.47 target 25.24 stop loss @ 20.41 Details The technical summary data tells us to buy SGRY near 20.47 with an upside target of 25.24. This data also tells us to set a stop loss @ 20.41 ...

US markets wrapped up a blockbuster 2024 by marking an achievement so rare that it’s only ever happened a handful of times. Despite US stocks closing lower Tuesday in a disappointing December ...

Hours before ringing in the new year, the CEO of X, formerly Twitter, announced the platform will launch a payment system, X Money, in 2025. In an X post on Tuesday afternoon, CEO Linda Yaccarino ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

If you love investing in stocks you're bound to buy some losers. But the last three years have been particularly tough on longer term Surgery Partners, Inc. (NASDAQ:SGRY) shareholders. Unfortunately, ...